PharmSource is pleased to present our special 2017 DCAT edition of Bio/Pharmaceutical Outsourcing Report. This monthly publication, brought to you by PharmSource’s experts, keeps you on top of the latest industry news, with analysis on its impact for the industry and on your business – critical information for helping you navigate in the contract services arena.

Bio/Pharmaceutical Outsourcing Report is just one of the great resources our STRATEGIC ADVANTAGE subscribers receive.
 
 

To receive a complimentary PDF copy of this special edition, please fill out this form:

Table of Contents

Business Conditions
• Is M&A Really Consolidating the CMO Industry?

Commercial Dose Manufacturing and Packaging
• Famar Taken Over by Restructuring Firm

API — Large Molecule
• AGC Acquires CMC Biologics

Side Effects
• Impacts of Key Events on CMOs and CROs

API — Small Molecule
• Expanding Oligonucleotide Indications Draw CMO Attention

PharmSource Strategic Advantage
• Market Intelligence Service Delivers Key Strategic Insights